Clinical Trial: Personalized Therapy of Long-term Low FODMAP in IBS Treatment: Role of Mobile Application and "Microbiota-gut-brain" Axis

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543354) titled 'Personalized Therapy of Long-term Low FODMAP in IBS Treatment: Role of Mobile Application and "Microbiota-gut-brain" Axis' on April 14.

Brief Summary: The purpose of this study is to evaluate the effectiveness of a mobile application (app) in helping clinicians and dietitians provide personalized low-FODMAP diet (LFD) therapy for patients with Irritable Bowel Syndrome (IBS). The study also aims to explore the potential biological mechanisms behind the clinical outcomes of this dietary intervention.

Participants diagnosed with IBS will be recruited and screened through clinical questionnaires. Eligible participants will receive die...